EUVIMEDEUVIMED entdecken
Crossref

A Nonbactericidal Anionic Antimicrobial Peptide Provides Prophylactic and Therapeutic Efficacies against Bacterial Infections in Mice by Immunomodulatory–Antithrombotic Duality

Yanmei He iD, Shimei Ruan, Guozhu Liang, Jing Hao, Xiaoyan Zhou, Zhuorui Li, Lixian Mu, Jing Wu, Hailong Yang

Journal of Medicinal Chemistry · 2024

DOI: 10.1021/acs.jmedchem.4c00342 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Medicinal Chemistry, 2024. Verfasst von Yanmei He und 8 weiteren Autor:innen. Beteiligte Einrichtung: School of Basic Medical Sciences, Kunming Medical University, Kunming 650500, Yunnan, China. Hauptthemen laut MEDLINE: Anti-Bacterial Agents, Antimicrobial Peptides. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 61 Literaturangaben. Gefördert von: Applied Basic Research Foundation of Yunnan Province, Fellowships for Young International Scientists, National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Although bactericidal cationic antimicrobial peptides (AMPs) have been well characterized, less information is available about the antibacterial properties and mechanisms of action of nonbactericidal AMPs, especially nonbactericidal anionic AMPs. Herein, a novel anionic antimicrobial peptide (Gy-CATH) with a net charge of -4 was identified from the skin of the frog Glyphoglossus yunnanensis. Gy-CATH lacks direct antibacterial effects but exhibits significantly preventive and therapeutic capacities in mice that are infected with Staphylococcus aureus, Enterobacteriaceae coli, methicillin-resistant Staphylococcus aureus (MRSA), or carbapenem-resistant E. coli (CREC). In vitro and in vivo investigations proved the regulation of Gy-CATH on neutrophils and macrophages involved in the host immune defense against infection. Moreover, Gy-CATH significantly reduced the extent of pulmonary fibrin deposition and prevented thrombosis in mice, which was attributed to the regulatory role of Gy-CATH in physiological anticoagulants and platelet aggregation. These findings show that Gy-CATH is a potential candidate for the treatment of bacterial infection.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Anti-Bacterial AgentsAntimicrobial PeptidesAnimalsMiceAnuraBacterial InfectionsEscherichia coliFibrinolytic AgentsImmunologic FactorsMethicillin-Resistant Staphylococcus aureusMicrobial Sensitivity TestsThrombosis

Substanzen

Anti-Bacterial AgentsAntimicrobial PeptidesFibrinolytic AgentsImmunologic Factors

Autor:innen und Institutionen

  • School of Basic Medical Sciences, Kunming Medical University, Kunming 650500, Yunnan, China.

ORCID-Profile: Yanmei He

Förderung

  • Applied Basic Research Foundation of Yunnan Province
  • Fellowships for Young International Scientists
  • National Natural Science Foundation of China

Zitieren

APA

He, Y., Ruan, S., Liang, G., Hao, J., Zhou, X., Li, Z., Mu, L., Wu, J., & Yang, H. (2024). A Nonbactericidal Anionic Antimicrobial Peptide Provides Prophylactic and Therapeutic Efficacies against Bacterial Infections in Mice by Immunomodulatory–Antithrombotic Duality. Journal of Medicinal Chemistry. https://doi.org/10.1021/acs.jmedchem.4c00342

Vancouver

He Y, Ruan S, Liang G, Hao J, Zhou X, Li Z, et al. A Nonbactericidal Anionic Antimicrobial Peptide Provides Prophylactic and Therapeutic Efficacies against Bacterial Infections in Mice by Immunomodulatory–Antithrombotic Duality. Journal of Medicinal Chemistry. 2024. doi:10.1021/acs.jmedchem.4c00342

BibTeX
@article{He2024,
  author = {He, Yanmei and Ruan, Shimei and Liang, Guozhu and Hao, Jing and Zhou, Xiaoyan and Li, Zhuorui and Mu, Lixian and Wu, Jing and Yang, Hailong},
  title = {A Nonbactericidal Anionic Antimicrobial Peptide Provides Prophylactic and Therapeutic Efficacies against Bacterial Infections in Mice by Immunomodulatory–Antithrombotic Duality},
  journal = {Journal of Medicinal Chemistry},
  year = {2024},
  doi = {10.1021/acs.jmedchem.4c00342}
}
Kostenlos starten →